Novel pyrrole-containing histone deacetylase inhibitors endowed with cytodifferentiation activity

International Journal of Biochemistry and Cell Biology

Volumn 39, Issue 7-8, 2007, Pages 1510-1522

  Mai, Antonello ^a   Valente, Sergio ^a   Rotili, Dante ^a   Massa, Silvio ^b   Botta, Giorgia ^a   Brosch, Gerald ^c   Miceli, Marco ^d   Nebbioso, Angela ^d   Altucci, Lucia ^d,e  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d SECOND UNIVERSITY OF NAPLES   (Italy)

^e CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

Author keywords

Apoptosis; Aroyl pyrrolyl hydroxyamides; Granulocytic differentiation; Histone deacetylase inhibitors; Pyrrole containing compounds

Indexed keywords

ALPHA TUBULIN; HISTONE; HISTONE DEACETYLASE INHIBITOR; PYRROLE;

ACETYLATION; APOPTOSIS; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE; CYTOLOGY; GRANULOCYTE; HUMAN; LEUKEMIA; STATISTICAL SIGNIFICANCE;

ACETYLATION; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; GRANULOCYTES; HISTONE DEACETYLASES; HISTONES; HUMANS; PYRROLES; STRUCTURE-ACTIVITY RELATIONSHIP; TUBULIN; U937 CELLS;

ZEA MAYS;

EID: 34447268739     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2007.03.020     Document Type: Article

References (38)

1. Altucci L., Rossin A., Raffelsberger W., Reitmair A., Chomienne C., and Gronemeyer H. Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL. Nat. Med. 7 (2001) 680-686
2. Blander G., and Guarente L. The Sir2 family of protein deacetylases. Annu. Rev. Biochem. 73 (2004) 417-435
3. Brosch G., Goralik-Schramel M., and Loidl P. Purification of histone deacetylase HD1-A of germinating maize embryos. FEBS Lett. 393 (1996) 287-291
4. Brosch G., Lusser A., Goralik-Schramel M., and Loidl P. Purification and characterization of a high molecular weight histone deacetylase complex (HD2) of maize embryos. Biochemistry 35 (1996) 15907-15914
5. Cheung W.L., Briggs S.D., and Allis C.D. Acetylation and chromosomal functions. Curr. Opin. Cell Biol. 12 (2000) 326-333
6. Ferreira R., Magnaghi-Jaulin L., Robin P., Harel-Bellan A., and Trouche D. The three members of the pocket proteins family share the ability to repress E2F activity through recruitment of a histone deacetylase. Proc. Natl. Acad. Sci. U. S. A. 95 (1988) 10493-10498
7. Gregoretti I.V., Lee Y.-M., and Goodson H.V. Molecular evolution of the Histone deacetylase family: Functional implications of phylogenetic analysis. J. Mol. Biol. 338 (2004) 17-31
8. Grozinger C.M., and Schreiber S.L. Deacetylase enzymes: Biological functions and the use of small-molecule inhibitors. Chem. Biol. 9 (2002) 3-16
9. Haggarty S.J., Koeller K.M., Wong J.C., Grozinger C.M., and Schreiber S.L. Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 4389-4394
10. Heinzel T., Lavinsky R.M., Mullen T.-M., Soderstrom M., Laherty C.D., Torchia J., et al. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 87 (1997) 43-48
11. Johnstone R.W. Histone deacetylase inhibitors: novel drugs for the treatment of cancer. Nat. Rev. Drug Discov. 1 (2002) 287-299
12. Kelly W.K., O'Connor O.A., and Marks P.A. Histone deacetylase inhibitors: From target to clinical trials. Expert Opin. Investig. Drugs 11 (2002) 1695-1713
13. Kölle D., Brosch G., Lechner T., Lusser A., and Loidl P. Biochemical methods for analysis of histone deacetylases. Methods 15 (1998) 323-331
14. Kölle D., Brosch G., Lechner T., Pipal A., Helliger W., Taplick J., et al. Different types of maize histone deacetylases are distinguished by a highly complex substrate and site specificity. Biochemistry 38 (1999) 6769-6773
15. Kouzarides T. Histone acetylases and deacetylases in cell proliferation. Curr. Opin. Genet. Dev. 9 (1999) 40-48
16. Lechner T., Lusser A., Brosch G., Eberharter A., Goralik-Schramel M., and Loidl P. A comparative study of histone deacetylases of plant, fungal and vertebrate cells. Biochim. Biophys. Acta 1296 (1996) 181-188
17. Lechner T., Lusser A., Pipal A., Brosch G., Loidl A., Goralik-Schramel M., et al. RPD3-type histone deacetylases in maize embryos. Biochemistry 39 (2000) 1683-1692
18. Lusser A., Brosch G., Loidl A., Haas H., and Loidl P. Identification of maize histone deacetylase HD2 as an acidic nucleolar phosphoprotein. Science 277 (1997) 88-91
19. Mai A., Massa S., Cerbara I., Valente S., Ragno R., Bottoni P., et al. 3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamides as a new class of synthetic histone deacetylase inhibitors. 2. Effect of Pyrrole C2 and/or C4 substitutions on biological activity. J. Med. Chem. 47 (2004) 1098-1109
20. Mai A., Massa S., Ragno R., Cerbara I., Jesacher F., Loidl P., et al. 3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-alkylamides as a new class of synthetic histone deacetylase inhibitors. 1. Design, synthesis, biological evaluation, and binding mode studies performed through three different docking procedures. J. Med. Chem. 46 (2003) 512-524
21. Mai A., Massa S., Ragno R., Esposito M., Sbardella G., Nocca G., et al. Binding mode analysis of 3-(4-benzoyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamide: A new synthetic histone deacetylase inhibitor inducing histone hyperacetylation, growth inhibition, and terminal cell differentiation. J. Med. Chem. 45 (2002) 1778-1784
22. Mai A., Massa S., Rotili D., Cerbara I., Valente S., Pezzi R., et al. Histone deacetylation in epigenetics: An attractive target for anticancer therapy. Med. Res. Rev. 25 (2005) 261-309
23. Mai A., Massa S., Valente S., Simeoni S., Ragno R., Bottoni P., et al. Aroyl-pyrrolyl hydroxyamides: influence of pyrrole C4-phenylacetyl substitution on histone deacetylase inhibition. ChemMedChem 1 (2006) 225-237
24. Marks P.A., Rifkind R.A., Richon V.M., Breslow R., Miller T., and Kelly W.K. Histone deacetylases and cancer: Causes and therapies. Nat. Rev. Cancer 1 (2001) 194-202
25. Massa S., Mai A., Sbardella G., Esposito M., Ragno R., Loidl P., et al. 3-(4-Aroyl-1H-pyrrol-2-yl)-N-hydroxy-2-propenamides, a new class of synthetic histone deacetylase inhibitors. J. Med. Chem. 44 (2001) 2069-2072
26. Minucci S., and Pelicci P.G. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat. Rev. Cancer 6 (2006) 38-51
27. Mori K., and Koseki K. Synthesis of trichostatin A, a potent differentiation inducer of Friend leukemic cells, and its antipode. Tetrahedron 44 (1988) 6013-6020
28. Nebbioso A., Clarke N., Voltz E., Germain E., Ambrosino C., Bontempo P., et al. Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells. Nat. Med. 11 (2005) 77-84
29. Ng H.H., and Bird A. Histone deacetylases: Silencers for hire. Trends Biochem. Sci. 25 (2000) 121-126
30. Ragno R., Mai A., Massa S., Cerbara I., Valente S., Bottoni P., et al. 3-(4-Aroyl-1-methyl-1H-pyrrol-2-yl)-N-hydroxy-2-propenamides as a new class of synthetic histone deacetylase inhibitors. 3. Discovery of novel lead compounds through structure-based drug design and docking studies. J. Med. Chem. 47 (2004) 1351-1359
31. Richon V.M., Emiliani S., Verdin E., Webb Y., Breslow R., Rifkind R.A., et al. A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 3003-3007
32. Sambucetti L.C., Fischer D.D., Zabludoff S., Kwon P.O., Chamberlin H., Trogani N., et al. Histone deacetylase inhibition selectively alters the activity and expression of cell cycle proteins leading to specific chromatin acetylation and antiproliferative effects. J. Biol. Chem. 274 (1999) 34940-34947
33. Sinisterra J.V., Mouloungui Z., Delmas M., and Gaset A. Barium hydroxide as catalyst in organic reactions. V. Application in the Horner reaction under solid-liquid phase-transfer conditions. Synthesis (1985) 1097-1100
34. Strahl B.D., and Allis C.D. The language of covalent histone modifications. Nature 403 (2000) 41-45
35. Verdin E., Dequiedt F., and Kasler H.G. Class II histone deacetylases: Versatile regulators. Trends Genet. 19 (2003) 286-293
36. Wolffe A.P., and Guschin D. Chromatin structural features and targets that regulate transcription. J. Struct. Biol. 129 (2000) 102-122
37. Wu J., and Grunstein M. 25 Years after the nucleosome model: Chromatin modifications. Trends Biochem. Sci. 25 (2000) 619-623
38. Yoshida M., Kijima M., Akita M., and Beppu T. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by Trichostatin A. J. Biol. Chem. 265 (1990) 17174-17179